Trials / Completed
CompletedNCT05301907
Survey Among Healthcare Professionals and MS Patients to Assess Their Understanding of RMP Materials
Survey Among Healthcare Professionals and MS Patients/Caregivers in Selected European Countries to Evaluate the Knowledge Required for the Safe Use of Mayzent
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 335 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Survey to be completed independently by HCPs (neurologists treating patients with MS and MS specialist nurses) and patients/caregivers.
Detailed description
The survey- based study was conducting amongst HCPs and patients/caregivers in selected European countries including Germany, Netherlands, Nordics (Denmark, Sweden), Spain and Croatia, plus Canada, to evaluate whether HCPs and patients/caregivers receive the educational materials and to capture their knowledge of specific Mayzent (siponimod) safety measures.
Conditions
Timeline
- Start date
- 2021-12-02
- Primary completion
- 2025-05-16
- Completion
- 2025-05-16
- First posted
- 2022-03-31
- Last updated
- 2025-12-24
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT05301907. Inclusion in this directory is not an endorsement.